GeneDx Holdings Corp.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving GeneDx Holdings Corp. now
Current reporting with the operating signal separated from the noise.
GeneDx Holdings Corp. (WGS) Q2 earnings and revenues surpass estimates
Investors are testing whether GeneDx Holdings Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx ...
The development tests whether GeneDx Holdings Corp. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.GeneDx Holdings Corp. (WGS) Fell Following a Significant Cut in 2026 Guidance
The story matters when it changes GeneDx Holdings Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
The story matters when it changes GeneDx Holdings Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
Investors are testing whether GeneDx Holdings Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
The development tests whether GeneDx Holdings Corp. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates
Investors are testing whether GeneDx Holdings Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest WGS filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
GeneDx Holdings Corp., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →